Last reviewed · How we verify
Pankreozymin (pancreozymin)
Pankreozymin (generic name: pancreozymin) is a drug. It is currently in unknown development for Pancreatic function test.
Pankreozymin works by binding to the cholecystokinin receptor type A, mimicking the natural hormone cholecystokinin.
Pankreozymin (pancreozymin) is a small molecule that targets the cholecystokinin receptor type A. It is used for pancreatic function tests, but its commercial status and pharmacokinetic properties are unknown. As a pancreatic function test agent, it is not intended for therapeutic use. The safety considerations of Pankreozymin are unclear due to a lack of available information. Further research is needed to fully understand its effects and potential risks.
At a glance
| Generic name | pancreozymin |
|---|---|
| Target | Cholecystokinin receptor type A |
| Therapeutic area | Gastroenterology |
| Phase | unknown |
Mechanism of action
Imagine your pancreas as a factory that produces digestive enzymes. Cholecystokinin is a hormone that tells the pancreas to release these enzymes into the small intestine to help break down food. Pankreozymin is a synthetic version of this hormone that triggers the same response, allowing doctors to test how well the pancreas is functioning.
Approved indications
- Pancreatic function test
Common side effects
Key clinical trials
- Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC (NA)
- POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS (NA)
- Proglumide and Chemotherapy for Metastatic Pancreatic Cancer (PHASE2)
- A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms (PHASE1)
- The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying (NA)
- Fatty Acids in Airway Smooth Muscle of Asthmatics (NA)
- Effect of Coffee Consumption on Appetite Traits in Overweight and Obesity (NA)
- Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis (PHASE1,PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pankreozymin CI brief — competitive landscape report
- Pankreozymin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Pankreozymin
What is Pankreozymin?
How does Pankreozymin work?
What is Pankreozymin used for?
What is the generic name of Pankreozymin?
What development phase is Pankreozymin in?
What does Pankreozymin target?
Related
- Target: All drugs targeting Cholecystokinin receptor type A
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Gastroenterology
- Indication: Drugs for Pancreatic function test
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing